throbber
American Journal of Hematology 60:36–47 (1999)
`
`Evidence for Involvement of Tumor Necrosis Factor-a in
`Apoptotic Death of Bone Marrow Cells in
`Myelodysplastic Syndromes
`
`Suneel D. Mundle,* Ambereen Ali, Jonathan D. Cartlidge, Samina Reza, Sairah Alvi,
`Margaret M. Showel, B. Yifwayimare Mativi, Vilasini T. Shetty, Parameswaran Venugopal,
`Stephanie A. Gregory, and Azra Raza
`Rush Cancer Institute, Rush-Presbyterian-St. Luke’s Medical Center, Chicago, Illinois
`
`We previously reported excessive apoptosis and high levels of tumor necrosis factor-
`alpha (TNF-a) in the bone marrows of patients with myelodysplastic syndromes (MDS),
`using histochemical techniques. The present studies provide further circumstantial evi-
`dence for the involvement of TNF-a in apoptotic death of the marrow cells in MDS. Using
`our newly developed in situ double-labeling technique that sequentially employs DNA
`polymerase (DNA Pol) followed by terminal deoxynucleotidyl transferase (TdT) to label
`cells undergoing apoptosis, we have characterized DNA fragmentation patterns during
`spontaneous apoptosis in MDS bone marrow and in HL60 cells treated with TNF-a or
`etoposide (VP16). Clear DNA laddering detected by gel electrophoresis in MDS samples
`confirmed the unique length of apoptotic DNA fragments (180–200 bp). Surprisingly,
`however, phenotypically heterogeneous population of MDS cells as well as the homog-
`enous population of HL60 cells showed three distinct labeling patterns after double
`labeling—only DNA-Pol reaction, only TdT reaction, and a combined DNA Pol + TdT
`reaction, albeit in different cohorts of cells. Each labeling pattern was found at all mor-
`phological stages of apoptosis. MDS mononuclear cells, during spontaneous apoptosis
`in 4 hr cultures, showed highest increase in double-labeled cells (DNA Pol + TdT reac-
`tion). Interestingly, this was paralleled by TNF-a–induced apoptosis in HL60 cells. In
`contrast, VP16 treatment of HL60 cells led to increased apoptosis in cells showing only
`TdT reaction. The double-labeling technique was applied to normal bone marrow and
`peripheral blood mononuclear cells after treatment with known endonucleases that spe-
`cifically cause 3* recessed (BamHI), 5* recessed (PstI), or blunt ended (DraI) double-
`stranded DNA breaks. It was found that the DNA-Pol reaction in MDS and HL60 cells
`corresponds to 3* recessed DNA fragments, the TdT reaction to 5* recessed and/or blunt
`ended fragments, and a combined ‘‘DNA Pol + TdT reaction’’ corresponds to a copres-
`ence of 3* recessed with 5* recessed and/or blunt ended fragments. Clearly, therefore,
`apoptotic DNA fragments, in spite of a unique length, may have differently staggered
`ends that could be cell (or tissue) specific and be selectively triggered by different in-
`ducers of apoptosis. The presence of TNF-a–inducible apoptotic DNA fragmentation
`pattern in MDS supports its involvement in these disorders and suggests that anti–TNF-a
`(or anticytokine) therapy may be of special benefit to MDS patients, where no definitive
`treatment is yet available. Am. J. Hematol. 60:36–47, 1999.
`© 1999 Wiley-Liss, Inc.
`
`Key words: human disorders; myelodysplastic syndromes (MDS); HL60cells; apoptosis;
`DNA fragmentation; in situ labeling; tumor necrosis factor-a (TNF-a); etoposide (VP16);
`hematopoietic disorders
`
`A. Ali is a Research Fellow of the National Cancer Institute of Canada
`supported with funds provided by the Terry Fox Run.
`
`Luke’s Medical Center, 2242 West Harrison Street, Suite 108, Chi-
`cago, IL 60612. E-mail: smundle@rush.edu
`
`*Correspondence to: Suneel D. Mundle, Ph.D., Assistant Professor,
`Rush Medical College, Rush Cancer Institute, Rush-Presbyterian-St.
`
`Received for publication 8 December 1997; Accepted 2 September
`1998
`
`DR. REDDY’S LABS., INC. EX. 1027 PAGE 1
`
`

`

`INTRODUCTION
`
`In the past we showed that hematopoietic as well as
`stromal cells in the bone marrows (BMs) of patients with
`myelodysplastic syndromes (MDS) demonstrate exces-
`sive apoptotic death, thus forming the basis for ineffec-
`tive hematopoiesis observed in these disorders [1–3].
`Others have confirmed our observation of high intramed-
`ullary apoptosis in MDS [4,5]. Such a widespread inci-
`dence of apoptosis affecting all types of bone marrow
`cells was indicative of a possible involvement of cyto-
`kine(s) with a broad range of target cells. Using immu-
`nohistochemistry, we indeed detected high levels of tu-
`mor necrosis factor-alpha (TNF-a) correlating signifi-
`cantly with the levels of apoptosis detected in situ in the
`same BM biopsies of MDS patients [3]. In our attempts
`to further understand the association between TNF-a and
`apoptosis in MDS, in the present studies we examined
`the patterns of DNA fragmentation during spontaneous
`apoptosis in MDS and in TNF-a–induced apoptosis in
`HL60 cells.
`Internucleosomal DNA fragmentation constitutes one
`of the most salient features of apoptotic cell death. The
`four endonucleases most prominently implicated in
`apoptotic DNA fragmentation are Ca++ Mg++ dependent,
`Mg++ dependent, Mn++ dependent, and acidic endonucle-
`ase. These endonucleases have been shown to maintain
`the property of internucleosomal cleavage [6–8]. No spe-
`cific differences with respect to substrate requirement or
`products formed have been noted among different apop-
`totic endonucleases. The DNA fragments formed by such
`endonucleolytic activity that typically appear to have
`58-P and 38-OH terminals [9–11], could be detected using
`two specific enzymatic reactions that label the ends of
`DNA fragments. One of these techniques uses DNA
`Polymerase (DNA Pol) or Klenow fragment of DNA Pol
`[10] whereas the other uses terminal deoxynucleotidyl
`transferase (TdT) for this purpose [9]. We have exten-
`sively used these enzymatic reactions to detect apoptosis
`in situ in a variety of clinical samples [1–3,12,13]. In one
`of these studies, we compared the labeling of apoptosis
`by the two enzymatic reactions performed separately in
`serial sections of different types of solid tumors. It was
`found that some tissues like breast tumors or primary
`brain tumors did not show labeling with DNA Pol, but
`showed positivity with TdT labeling [12,13]. On the
`other hand, tissues like nonHodgkin’s lymphoma or head
`and neck squamous cell carcinoma showed comparable
`labeling by the two enzymes in serial biopsy sections
`[12]. Gold et al. [14] in 1994 reported that whereas DNA
`Pol preferentially labels necrosis, TdT was more specific
`for apoptosis. Contrastingly, we found that both methods
`label apoptosis as well as necrosis except that necrosis is
`labeled with an extremely low intensity by both methods
`[12,15].
`
`Involvement of TNF-a in Myelodysplasia
`
`37
`
`To explain the tissue-specific differences in labeling
`with DNA Pol and TdT noted in our studies, we hypoth-
`esized that the apoptotic DNA fragments may have a
`unique length of integral multiples of 180–200 bp, but
`have differently staggered ends—38 recessed, 58 re-
`cessed, or blunt—perhaps reflecting the specificity of the
`endogenous endonuclease(s) involved. To test this pos-
`tulate we developed an in situ double-labeling technique
`in which the DNA-Pol reaction is performed first, fol-
`lowed by the TdT reaction. Using this technique, as de-
`scribed in the present paper, we have now been able to
`confirm our hypothesis and characterize and compare the
`ends of apoptotic DNA fragments in spontaneous apop-
`tosis in MDS with that induced by TNF-a in HL60 cells.
`The findings of these studies reported in the present pa-
`per highlighting their therapeutic implications suggest a
`novel approach to the treatment of MDS.
`
`MATERIALS AND METHODS
`
`Patients
`
`Sixteen bone marrow aspirate specimens from 15 pa-
`tients with a confirmed diagnosis of MDS [diagnosed
`according to the French-American-British classification
`as refractory anemia (RA)-7, RA with ringed sideroblasts
`(RARS)-3, RA with excess of blasts (RAEB)-3, RA with
`excess of blasts in transformation (RAEBt)-1, and
`Chronic myelomonocytic leukemia (CMMoL)-1] were
`studied for the incidence of spontaneous apoptosis. One
`MDS patient (RARS) was studied on two occasions. Six
`normal bone marrows from healthy donors were studied
`for comparison. The protocols, MDS 90 02 and MDS 95
`01, under which clinical specimens were obtained, were
`approved by the local Institutional Review Board (IRB)
`and informed consent was obtained from the donors.
`Bone marrow aspirates were subjected to Ficoll-Hypaque
`density gradient centrifugation to separate mononuclear
`cells. After confirming the viability by trypan blue dye
`exclusion test, cells were suspended (1 × 106 cells/ml) in
`RPMI-1640 medium (GIBCO-BRL Life Technologies
`Inc., Grand Island, NY) supplemented with 10% fetal
`bovine serum (FBS) (GIBCO-BRL), 100 U/ml penicillin,
`100 mg/ml streptomycin, and 2 mM/l glutamine (com-
`plete medium). One aliquot was used for 0 hr tests and
`the other was incubated for 4 hr at 37°C in the presence
`of 5% CO2. At both time points, cells were washed and
`divided into two aliquots. One was fixed on alcian blue
`coated coverslips using 4% buffered paraformaldehyde
`(pH 7.1) overnight at 4°C and stored in 70% ethanol until
`in situ tests for detection of apoptosis were performed.
`The other aliquot was used to extract DNA following cell
`lysis in guanidine isothiocyanate (GITC) as described
`previously [12].
`
`DR. REDDY’S LABS., INC. EX. 1027 PAGE 2
`
`

`

`38
`
`Mundle et al.
`
`HL60 Cell Cultures
`HL60 cells were maintained in RPMI-1640 complete
`medium supplemented with 20% FBS. Freshly harvested
`cells, after confirming viability by trypan blue dye ex-
`clusion test, were resuspended (1 × 106 cells/ml) in com-
`plete medium and treated with human recombinant
`TNF-a (0.01 ng/ml; Promega Inc., Madison, WI) for 8 hr
`or with VP16 (etoposide—35 mM/l; Bristol Laboratories,
`Princeton, NJ) for 4 hr. As both these agents were dis-
`solved in RPMI 1640, cells suspended in plain complete
`medium and incubated for a maximum interval, i.e., 8 hr
`served as controls. The dose of TNF-a was chosen based
`on the ED50 dose (0.016 ng/ml) suggested by the manu-
`facturer and according to our initial dose response ex-
`periments, which showed a linear apoptotic response at
`0.01 ng/ml until 8 hr (data not shown). The concentration
`and incubation time of VP16 was based on our previous
`studies [12]. Cells were fixed on alcian blue coated cov-
`erslips using 4% paraformaldehyde before and after the
`designated time of incubation, and stored in 70% ethanol
`for in situ detection of apoptosis. Experiments were re-
`peated four times and the results represent the average of
`four experiments.
`
`Single Labeling of Apoptosis With DNA Pol I
`or TdT
`These techniques to detect apoptotic cell death in situ
`have been described in detail in previous reports by us
`[1–3,12] and others [9,10]. Briefly, cells were rehy-
`drated, postfixed in 0.23% periodic acid, and pretreated
`with SSC solution (30 mM/l sodium citrate + 0.3 M/l
`sodium chloride, pH 7.0) at 80°C for 20 min. The cells
`were then treated with either a mixture of deoxyribo-
`nucleotides, one of which was biotinylated (11 bio-
`dUTP; Sigma, St. Louis, MO) and E. coli DNA Pol I
`(Promega, Madison, WI) or with 11 bio-dUTP and TdT
`(Promega). Incorporation of labeled nucleotide was vi-
`sualized using avidin-biotin-horseradish peroxidase
`(Vectastain Elite ABC kit, Vector, Burlingame, CA) and
`diaminobenzidine tetrahydrochloride (DAB). Dark
`brown nuclear staining indicated cells that were under-
`going apoptotic death.
`
`Double Labeling With DNA Pol I and TdT
`
`Cells were rehydrated, postfixed with 0.23% periodic
`acid, and pretreated with SSC solution. Subsequently,
`cells were washed in buffer A, pH 7.5 (50 mM/l Tris
`hydrochloride, 5 mM/l magnesium chloride, 10 mM/l b
`mercaptoethanol, and 0.005% bovine serum albumin,
`fraction V) (Sigma) and treated with a cocktail of four
`deoxynucleotides, one of which was biotinylated (bio
`dUTP) and DNA Pol I prepared in buffer A [0.01 mM/l
`of dATP, dCTP, and dGTP (Promega) + 0.001 mM/l bio
`dUTP (Sigma) and 20 U/ml Escherichia coli DNA Pol I
`
`(Promega)] at 18–19°C for 2 hr. The DNA-Pol reaction
`was visualized with ABC and DAB giving brown nuclear
`staining. Subsequently, cells were washed with buffer B,
`pH 6.8 (100 mM/l sodium cacodylate, 0.1 mM/l dithio-
`threitol, 5 mM/l cobalt chloride) (Sigma) and treated with
`a mixture of TdT (10 U/ml) and 0.001 mM/l digoxigenin-
`dUTP (Boehringer Mannheim, Germany) prepared in
`TdT buffer. The reaction was performed at 37°C for 1 hr
`and was terminated by immersing the coverslips in SSC
`solution. Incorporation of digoxigenin-dUTP was de-
`tected using antidigoxigenin Fab fragment conjugated
`with alkaline phosphatase (1:100 diluted; Boehringer
`Mannheim, Germany). The cells were then immersed in
`a solution freshly prepared as follows: Naphthol As-Mx
`Phosphate (20 mg; Sigma) was dissolved in 2 ml of
`N-N8-dimethylformamide (Sigma) and this was added to
`100 ml of 0.1 M/l Tris buffer, pH 8.2, at 20°C. Next, 0.1
`ml of 1 M/l levamisole was added to the solution to
`inhibit endogenous alkaline phosphatase, followed by
`100 mg of Fast blue BB salt (Sigma). This mixture was
`stirred for 2 min and then filtered. The coverslips were
`then immersed in this solution for 10–12 min. The cov-
`erslips were finally washed in distilled water and
`mounted in fluoromount. Positive TdT reaction thus
`stained nuclei blue.
`
`Controls for In Situ Labeling Procedures
`
`Specimens treated with the in situ end labeling reac-
`tion mixtures prepared in respective buffers with labeled
`nucleotide (and nucleotides for DNA Pol), but devoid of
`the enzyme (DNA Pol or TdT), served as negative assay
`controls.
`Treatment of normal human bone marrow and pe-
`ripheral blood mononuclear cells with known endo-
`nucleases. Normal bone marrow was collected from a
`resected rib procured during a thoracic surgical proce-
`dure and peripheral blood was obtained from a healthy
`donor under IRB approved protocols and with donors’
`written consent. Mononuclear cells were separated by
`density centrifugation and fixed on alcian blue coated
`coverslips with 4% paraformaldehyde and stored in 70%
`ethanol. The cells were rehydrated, postfixed with 0.23%
`periodic acid and pretreated with SSC solution as de-
`scribed above. At this point cells were subjected to dif-
`ferential treatments with known sequence specific endo-
`nucleases (Boehringer Mannheim) in respective reaction
`buffers provided along with the enzymes and at the over-
`digestion concentrations recommended by the manufac-
`turer as follows:
`
`1. BamHI (causes 38 recessed breaks with 58 over-
`hangs—58-Gfl GATCC-38) at 40 U/100 ml for 16 hr at
`37°C.
`2. PstI (causes 58 recessed breaks with 38 overhangs—
`58-CTGCAfl G-38) at 120 U/100 ml for 16 hr at 37°C.
`
`DR. REDDY’S LABS., INC. EX. 1027 PAGE 3
`
`

`

`3. DraI (causes blunt ended breaks—58-TTTfl AAA-38)
`at 120 U/100 ml for 16 hr at 37°C.
`4. PstI (120 U/100 ml) for 16 hr at 37°C followed by
`BamHI (20 U/100 ml) for 2 hr at 37°C.
`5. Mixture of PstI +DraI (120 U/100 ml each) for 16 hr
`at 37°C.
`
`At the end of treatments, cells were washed thoroughly
`with phosphate buffered saline and continued with
`double labeling as described above. Experiments were
`repeated to confirm the results.
`Determination of labeling index. Every specimen
`was carefully observed under light microscopy and 1–2
`thousand cells from several randomly selected 100× ob-
`jective fields were counted to determine the percent of
`labeled cells in each case. The significance of differences
`in the mean percent labeling indices in various test
`groups was determined by the Student’s t test. Also, the
`paired t test was used to determine the significance of
`differences in relative percent increase in labeling index
`of individual labeling patterns within each study group.
`
`RESULTS
`Spontaneous Apoptosis in MDS
`Our earlier studies showed an excessive incidence of
`spontaneous apoptosis in the bone marrows of MDS pa-
`tients in which a significant number of mononuclear cells
`from the bone marrow aspirates of these patients under-
`went apoptosis in 4-hr cultures in complete medium con-
`taining 10% serum [1,2]. Therefore, in the present study
`comparative labeling of Ficoll-separated mononuclear
`cells from 16 MDS aspirates and six normal aspirates,
`with DNA Pol and TdT was examined at 0 and 4 hr
`following incubation in vitro in a complete medium.
`Staining was performed after paraformaldehyde fixation
`at each time point. As shown in Figure 1, the mean
`labeling index of MDS cells at 4 hr by either enzymes
`was significantly higher than that at 0 hr. Furthermore,
`the labeling by the two enzymes at each time point was
`comparable (0.8% ± 0.4% at 0 hr vs. 3.9% ± 0.9% at 4
`hr, n 4 16, P 4 0.004, by DNA Pol, and 1.3% ± 0.4%
`at 0 hr vs. 3.8% ± 1.0% at 4 hr, n 4 10, P 4 0.046, by
`TdT). Interestingly, normal cells also showed a marginal
`but significant increase in labeling index in 4 hr (0.1% ±
`0.07% at 0 hr vs. 0.8% ± 0.1% at 4 hr, n 4 6, P 4 0.001,
`by DNA Pol, and 0.2% ± 0.08% at 0 hr vs. 1.5% ± 0.2%
`at 4 hr, n 4 5, P 4 0.005, by TdT). It is evident that at
`4 hr, the labeling indices of MDS cells were 2–3 times
`higher than those of normal cells (P 4 0.003 for DNA
`Pol and P 4 0.05 for TdT), hence confirming the in-
`creased propensity of MDS bone marrow cells to un-
`dergo spontaneous apoptosis in vitro.
`We subsequently performed our newly developed en-
`zymatic double labeling with DNA Pol/diaminoben-
`
`Involvement of TNF-a in Myelodysplasia
`
`39
`
`Fig. 1. Comparative detection of apoptosis in MDS and
`normal cells using DNA Pol or TdT single labeling: Bone
`marrow aspirate mononuclear cells from MDS and normal
`subjects were incubated in RPMI 1640 containing 10% FBS
`for 4 hr. Spontaneous apoptotic death was detected in these
`cells following fixation in 4% buffered paraformaldehyde,
`using single labeling with DNA Pol or TdT and bio-dUTP.
`Percent positively labeled cells (dark brown staining in the
`nuclei) were determined in each case. By either technique,
`the labeling index was significantly higher at 4 hr in MDS as
`well as in normal, but those in the former were 2–3 times
`higher than the latter, indicating higher propensity of MDS
`cells to undergo spontaneous apoptosis. No significant dif-
`ference was noted in the labeling efficiencies of the two
`enzymes at either time points within each group.
`
`zidine (brown staining) and TdT/fast blue (blue staining)
`systems, at the two time points on nine MDS and five
`normal specimens. Three distinct labeling patterns were
`observed both in MDS and normal specimens—cells
`with nuclei stained only brown (only DNA-Pol reaction),
`only blue (only TdT reaction), and double labeled (DNA
`Pol + TdT reaction). Interestingly, as depicted in Figure
`2, each labeling pattern was found at all phases of apop-
`tosis ranging from the early-stage nuclear margination to
`intermediate-stage chromatin condensation and clump-
`ing, to the end-stage karyorrhexis, indicating the main-
`tenance of labeling pattern throughout the process of ap-
`optosis at a single cell level. The increase in mean label-
`ing index in 4 hr, for each individual pattern was
`significant in MDS (Fig. 3a). In contrast, normal cells did
`not show a significant increase in individual patterns, but
`the increase in total index reached statistical significance
`(Fig. 3b).
`Parallel to these experiments, DNA fragmentation was
`also studied by agarose gel electrophoresis (MDS, n 4 8
`and normal, n 4 2). As illustrated in Figure 4, at 0 hr
`neither the MDS specimen (lane 2) nor the normal cells
`(lane 5) showed low molecular weight DNA fragments.
`However, after 4 hr MDS cells showed an intensely
`
`DR. REDDY’S LABS., INC. EX. 1027 PAGE 4
`
`

`

`40
`
`Mundle et al.
`
`Fig. 2. Double labeling of bone marrow
`aspirate mononuclear cells with DNA Pol/
`biotin-dUTP/diaminobenzidine (brown
`staining) and TdT/digoxigenin-dUTP/Fast
`blue (blue staining): As depicted here,
`both in MDS and normal specimens, three
`distinct labeling patterns were recog-
`nized: only-brown, only-blue, and dou-
`ble labeled. Furthermore, interestingly
`enough, each pattern was seen at early as
`well as late stages of apoptosis ranging
`from nuclear margination at early stage to
`larger clumping and fragmentation at late
`stages, e.g., double-labeled cells at early
`(B), intermediate (C), and late (D) stages
`or brown labeling at early (C) and late (A)
`stages seen in these micrographs. Origi-
`nal magnification, ×1000.
`
`stained, characteristic ladder of low molecular weight
`DNA fragments (lane 3), whereas the two normal speci-
`mens studied showed only a faint ladder (lane 6). One of
`the MDS specimens studied showed laddering at 0 hr
`also. The presence of clear laddering and lack of smear-
`ing in each case shows the absence of necrosis and con-
`firms apoptosis.
`
`TNF-a Vs. VP16-Induced Apoptosis in
`HL60 cells
`
`(Fig. 5b). In contrast, VP16 treatment showed the highest
`labeling indices with a remarkable increase in cells with
`only-TdT reaction and only a marginal increase in the
`other two patterns (Fig. 5c), with a significant increase in
`the total labeling index. Thus, at the end of the designated
`period of incubation, among individual labeling patterns,
`untreated cells and VP16-treated cells showed the high-
`est labeling indices in cells with only-TdT reaction,
`whereas TNF-a treated cells showed the highest indices
`in double-labeled cells (DNA Pol + TdT reaction).
`
`DNA fragmentation patterns were also studied in
`HL60 cells induced to undergo apoptosis by treatment
`with TNF-a (0.01 ng/ml for 8 hr) or VP16 (0.35 mM/l for
`4 hr). Cells incubated with vehicle only (culture medium)
`for the highest incubation period of 8 hr, served as con-
`trols. The experiments were repeated four times. Con-
`trols however were available from three experiments.
`DNA Pol/TdT double labeling was performed after para-
`formaldehyde fixation of cells before and after treatment
`in each experiment. The results described here represent
`the average of four experiments. Surprisingly, like MDS
`or normal cells, even the HL60 promyelocytic cells
`showed three distinct labeling patterns in each group. In
`the untreated group, during the 8-hr incubation, there was
`a slight increase in cells with only-DNA Pol reaction, a
`notable increase in cells with only-TdT reaction, and vir-
`tually no increase in double-labeled cells (Fig. 5a). On
`the other hand, TNF-a treatment induced an appreciable
`increase in the number of cells with only-DNA Pol re-
`action, virtually no increase in cells with only-TdT reac-
`tion, and a significant increase in double-labeled cells
`(DNA Pol + TdT reaction) and in total labeling index
`
`Comparison of Relative Percent Increase in
`Different Labeling Patterns in MDS, Normal, and
`HL60 Cells
`
`Considering the total net increase in percent positively
`labeled cells as 100%, relative percent increase in indi-
`vidual pattern was calculated in each case. Figure 6 com-
`pares the relative percent increase in individual labeling
`patterns during spontaneous apoptosis of MDS and nor-
`mal cells, and in HL60 cells with or without treatment.
`Normal cells showed a comparable increase in the three
`labeling patterns (only-DNA Pol reaction—30.6% ±
`19.5%; only-TdT reaction—39.8% ± 18.8%, and double
`labeled (DNA Pol + TdT reaction)—29.6% ± 11.2%, n
`4 5). On the other hand, MDS cells showed twice as
`much increase in double-labeled cells and in cells with
`only-DNA Pol reaction as compared with the cells with
`only-TdT reaction (39.2% ± 6.8%, P 4 0.08 and 38.6%
`± 5.3%, P 4 0.06 vs. 22.3% ± 6 %respectively, n 4 9).
`Surprisingly, TNF-a–treated HL60 cells exhibited a
`similar pattern to spontaneous apoptosis in MDS, show-
`ing the highest increase in double-labeled cells and the
`
`DR. REDDY’S LABS., INC. EX. 1027 PAGE 5
`
`

`

`Involvement of TNF-a in Myelodysplasia
`
`41
`
`Increase in individual label-
`Fig. 3.
`ing patterns in MDS and normal
`cells: Percentage of cells labeled
`positively for each individual stain-
`ing pattern were determined in MDS
`(a) and normal specimens (b). Note
`the significant increase observed in
`4 hr in each individual labeling pat-
`tern in MDS cells as compared with
`the normal cells, which showed
`marginal increase only in the total
`labeling index.
`
`least increase in cells with only-TdT reaction (double
`labeled—47.3% ± 4.4%, P 4 0.015 and only-DNA Pol
`reaction—32.2% ± 8.2%, P 4 0.3 vs. only-TdT reac-
`tion—20.5% ± 6.6%, n 4 4). The untreated and VP16-
`treated HL60 cells qualitatively showed a comparable
`pattern with relatively highest increase in cells with only-
`TdT reaction (69.9% ± 8.9%, P ł 0.01, n 4 3 and
`62.6% ± 15.5%, P ł 0.07, n 4 4 respectively), albeit
`quantitatively, the labeling indices after VP16 treatment
`were 10 times higher than those of untreated cells.
`
`Determination of Specific DNA Breaks Labeled by
`Individual Staining Patterns
`
`To determine if the individual staining patterns ob-
`served in our double-labeling experiments were related
`to specific types of DNA breaks, we treated normal hu-
`man bone marrow—and peripheral blood—mononuclear
`cells with different known sequence-specific endonucle-
`ases (also see Methods section and the legend to Figure
`7 for experimental details). Figure 7 shows staining in
`
`DR. REDDY’S LABS., INC. EX. 1027 PAGE 6
`
`

`

`42
`
`Mundle et al.
`
`Fig. 4. DNA ladder in MDS and normal cells: Agarose gel
`electrophoresis of DNA extracted from MDS and normal
`mononuclear cells, incubated for 4 hr in RPMI-1640 medium
`containing 10% FBS. (Ethidium bromide staining photo-
`graphed in ultraviolet light). At 0 hr neither MDS (lane 2) nor
`normal cells (lane 5) showed the presence of low molecular
`weight DNA bands. At 4 hr, whereas MDS cells showed in-
`tensely stained low molecular weight bands (lane 3), the
`normal cells showed only a faint ladder (lane 6), suggesting
`the internucleosomal DNA cleavage causing fragments of
`unique length.
`
`normal bone marrow mononuclear cells under different
`conditions, which was paralleled by that in peripheral
`blood cells (data not shown). These bone marrow mono-
`nuclear cells virtually showed no labeling in the absence
`of nucleolytic treatment (Fig. 7). Upon treatment with the
`three endonucleases, however, these cells showed a spe-
`cific staining pattern in each case, following in situ
`double labeling with DNA Pol and TdT. As illustrated in
`Figure 7, treatment with BamHI, which gives rise to 38
`recessed double-stranded DNA fragments with 58 over-
`hangs, showed only-DNA Pol specific brown staining of
`the nuclei. On the other hand, treatment with PstI that
`gives rise to double-stranded 58 recessed DNA fragments
`with 38 overhangs, or with DraI which generates blunt
`ended double-stranded DNA fragments, exclusively
`showed only-TdT specific blue staining. Interestingly,
`when cells were treated with both PstI and BamHI, as
`shown in Figure 7, the majority of positive cells were
`double labeled (DNA Pol + TdT reaction), whereas treat-
`ment with PstI and DraI demonstrated only-blue labeling
`(only-TdT reaction). Surprisingly, in the former case,
`double labeling was seen only when cells were treated
`sequentially with PstI first followed by BamHI, while a
`concomitant treatment with the two enzymes showed
`dominance of BamHI giving only-brown labeling (only-
`DNA Pol reaction; data not shown). On the other hand,
`sequential as well as concomitant treatment with PstI and
`
`DraI showed blue labeling only (only-TdT reaction).
`These experiments thus suggest that the brown labeling
`in MDS, normal, or HL60 cells could be due to the
`presence of 38 recessed DNA fragments, whereas the
`blue labeling may be due to the presence of 58 recessed
`and/or blunt-ended DNA fragments. Furthermore, the
`double labeling could be due to the copresence of 38
`recessed DNA fragments with 58 recessed or blunt-ended
`DNA fragments.
`
`DISCUSSION
`The mainstay in the therapy of MDS continues to be
`supportive care. Only through an in-depth understanding
`of the pathobiology of this intriguing disorder that we
`can hope to develop novel approaches in its treatment.
`Our present report not only provides a number of inter-
`esting insights into the biology of MDS and also into the
`process of apoptotic DNA fragmentation in general, but
`also shows a new ray of hope in the development of
`treatment for MDS. The most salient findings of these
`studies are summarized below and are subsequently dis-
`cussed in detail:
`1. The prominent DNA fragmentation pattern observed
`in spontaneous apoptosis of bone marrow cells in
`MDS is similar to that brought about by TNF-a treat-
`ment of HL60 cells.
`2. Apoptotic DNA fragments may have a unique length
`but have differently staggered ends.
`3. The two commonly used enzymes, DNA Pol and TdT,
`in a sequential double-labeling technique are now
`shown to differentiate the end patterns of apoptotic
`DNA fragments. DNA Pol can detect only 38 recessed
`DNA fragments, whereas TdT applied subsequently,
`detects 58 recessed and blunt-ended fragments. This
`observation defining the detection specificities of the
`two enzymes may warrant a caution in the current
`indiscriminate use of either enzyme singularly for de-
`tection of apoptosis.
`4. The characteristic DNA fragmentation pattern at a
`single cell level may be conserved throughout the pro-
`cess of apoptotic DNA disintegration.
`5. Different apoptotic stimuli could cause distinct DNA
`fragmentation patterns.
`Apototic death in the BMs of MDS patients dem-
`onstrates TNF-a–inducible DNA fragmentation pat-
`tern. In the present study apoptosis was studied in den-
`sity separated mononuclear cells from bone marrow as-
`pirates of MDS patients. The extent of apoptosis
`determined in bone marrow aspirate cells during very
`short-term (only 4 hr) in vitro incubation conditions ap-
`pears to be lower than the estimates reported previously
`in bone marrow biopsies by in situ studies by us and
`others [1,3,5]. However, our present estimates are in con-
`cordance with the estimates reported previously by us
`
`DR. REDDY’S LABS., INC. EX. 1027 PAGE 7
`
`

`

`Involvement of TNF-a in Myelodysplasia
`
`43
`
`Fig. 5. Double labeling of HL60 cells: Freshly
`harvested HL60 cells were treated with 0.01 ng/
`ml TNF-a (b) or 0.35 µM/l VP16 (c) in RPMI-1640
`medium containing 20% FBS. Cells incubated in
`plain medium served as controls (a). (n = num-
`ber of experiments) Percent positively labeled
`cells were determined following DNA Pol/TdT
`double labeling. Interestingly, untreated cells
`(a) and VP16-treated (c) cells showed the high-
`est increase in cells labeled with only-TdT reac-
`tion (only-blue staining), whereas following
`TNF-a treatment (b) the highest increase was
`found in cells double-labeled with DNA Pol +
`TdT reaction. The net increase in total labeling
`index was two times higher with TNF-a and al-
`most 10 times higher with VP16 treatment as
`compared with the untreated cells.
`
`and others in MDS aspirates [2,4]. Nonetheless, all pre-
`vious reports by others and us [1–5] are in complete
`agreement with the fact that MDS show higher apoptosis
`than normal in either type of specimen. In the present
`study, the MDS bone marrow cells showed 2–3 times
`higher propensity than the normal cells to spontaneously
`undergo apoptosis despite the presence of serum in the
`medium. When relative percent increase in different la-
`beling patterns of the total net increase was compared in
`normal, MDS, and HL60 cells, as shown in Figure 6, in
`normal cells the rate of increase in each individual label-
`ing pattern was comparable. Surprisingly in MDS, the
`comparative labeling pattern exhibited a similar profile
`as that demonstrated by the TNF-a–treated HL60 cells.
`Both showed the highest increase in cells double labeled
`
`with DNA Pol and TdT, and the least in those labeled by
`only-TdT reaction. Our earlier studies have shown ex-
`cessive apoptosis and higher levels of TNF-a in MDS
`marrows as compared with normal marrows [3]. Using a
`simultaneous histochemical double labeling for TNF-a
`and apoptosis, these studies also revealed high prepon-
`derance of TNF-a around cells undergoing apoptosis.
`The present studies thus provide further circumstantial
`evidence for the possible association of TNF-a with in-
`creased incidence of apoptosis in MDS.
`Apoptotic DNA fragments may have unique length
`but differently staggered ends. As mentioned earlier,
`the majority of apoptotic endonucleases appear to be to-
`pologically restricted in their action to the internucleo-
`somal linker region of DNA [6–8], which in general ap-
`
`DR. REDDY’S LABS., INC. EX. 1027 PAGE 8
`
`

`

`44
`
`Mundle et al.
`
`Fig. 6. Comparison of relative per-
`cent increase in individual labeling
`patterns of the total net increase in
`MDS, normal, and HL60 cells. As il-
`lustrated in the figure, whereas nor-
`mal cells showed comparable in-
`crease in the three patterns, MDS
`cells showed relatively highest in-
`crease in cells double labeled with
`DNA Pol + TdT reaction and least
`in cells with only-T

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket